Importance of Bcl-2-targeted therapies
John Gribben et al.
Treatment-associated atrial fibrillation: ibrutinib-specific or class-specific?
Tsunami of evidence in CLL
The research activities of the European Research Initiative on CLL (ERIC)
How to explain the 'watch-and-wait' period to a CLL patient?